Literature DB >> 3948433

The effects of polyinosinic: polycytidylic acid (pI:C) on the GVH reaction: immunopathological observations.

A Peres, T A Seemayer, W S Lapp.   

Abstract

The effects of polyinosinic: polycytidylic acid (pI:C) on the graft-versus-host (GVH) reaction were studied. The drug pI:C rapidly and markedly induces interferon and augments natural killer (NK) cell activity. GVH reactions were induced by injecting parental lymphoid cells intravenously into F1 hybrid mice. The development of a GVH reaction was monitored by measuring the plaque-forming cell (PFC) response to sheep red blood cells (SRBC) and by histological examination. When 30 X 10(6) B6 lymphoid cells were injected into B6AF1 mice, the recipients developed profound immunosuppression by 10-12 days post-GVH induction. In addition, pathological changes indicative of GVH reactions were seen in the spleen, lymph nodes, thymus, liver, lung, pancreas, and salivary gland of these mice. However, the treatment of B6AF1 recipients with pI:C prior to parental cell transfer markedly reduced the degree of suppression of the immune response, as measured by the PFC response to SRBC. Also, such mice failed to demonstrate the histological lesions of GVH disease. Treatment of donor mice with pI:C had no effect in preventing either GVH-induced immunosuppression or pathological changes. This study suggests that a pI:C-induced mechanism, possibly involving NK cells, is capable of regulating the GVH reaction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948433     DOI: 10.1016/0090-1229(86)90209-6

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  2 in total

1.  Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness.

Authors:  Soo Mun Ngoi; Marie-Clare St Rose; Antoine M Menoret; Dirk E Smith; Michael G Tovey; Adam J Adler; Anthony T Vella
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

2.  Broad-spectrum drugs against viral agents.

Authors:  Mary E Christopher; Jonathan P Wong
Journal:  Int J Mol Sci       Date:  2008-09-01       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.